TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials January 19, 1996
TCL Archive NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups November 6, 1998